wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33476874-BFED7C16-159E-485C-84FB-7D19A76FCFDB
Q33476874-BFED7C16-159E-485C-84FB-7D19A76FCFDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33476874-BFED7C16-159E-485C-84FB-7D19A76FCFDB
ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy
P2860
Q33476874-BFED7C16-159E-485C-84FB-7D19A76FCFDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33476874-BFED7C16-159E-485C-84FB-7D19A76FCFDB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5059db253d3425b500b46495fc1c5f0732e221e8
P2860
Resistance to imatinib mesylate in chronic myeloid leukaemia.